A. McGregor

发表

A Laboratory brucella exposure in a uk hospital: a swiss cheese model?

F. Begum, C. Tilsed, A. McGregor, 2019, The Journal of hospital infection.

Time to diagnosis of tuberculosis is greater in older patients: a retrospective cohort review

O. Kon, R. Davidson, L. John, 2019, ERJ Open Research.

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Nguyen H. Tran, Vidyashankara G. Iyer, Andreas C. Themistocleous, 2020, Lancet.

Multiple drug allergy syndrome in pregnancy: Lessons for sexual health physicians

A. McGregor, J. Mcsorley, Thajunnisha Mohamed Buhary, 2021, International journal of STD & AIDS.

Human liver flukes.

P. Lamberton, A. McGregor, D. Harrington, 2017, The lancet. Gastroenterology & hepatology.

Screening contacts of patients with extrapulmonary TB for latent TB infection

R. Davidson, L. John, A. McGregor, 2017, Thorax.

Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)

Nguyen H. Tran, V. Libri, G. Screaton, 2021, The Lancet.

Persistence of SARS-CoV-2 N-Antibody Response in Healthcare Workers, London, UK

Ross J. Harris, S. Ladhani, S. Hopkins, 2021, Emerging infectious diseases.

Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial.

J. Haughney, V. Libri, G. Screaton, 2022, Journal of Infection.

(2021). Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. The Lancet, 397(10269), 99-111.

S. Madhi, K. Dheda, P. Aley, 2020 .

Clinical characteristics and treatment outcomes in a cohort of patients with pyogenic and amoebic liver abscess

S. Collin, A. McGregor, G. Rao, 2019, BMC Infectious Diseases.

Gastrointestinal symptoms in travellers.

S. Wright, A. McGregor, 2015, Clinical medicine.

Geographic, symptomatic and laboratory predictors of parasitic and bacterial causes of diarrhoea in travellers.

C. Whitty, S. Wright, A. McGregor, 2012, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Prospects for prevention of Salmonella infection in children through vaccination

A. Pollard, A. McGregor, C. Waddington, 2013, Current opinion in infectious diseases.

An observational cohort study of bacterial co-infection and implications for empirical antibiotic therapy in patients presenting with COVID-19 to hospitals in North West London

P. Bassett, P. Khanna, A. McGregor, 2020, The Journal of antimicrobial chemotherapy.

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

Nguyen H. Tran, Vidyashankara G. Iyer, Andreas C. Themistocleous, 2021, The Lancet.

Experience of a novel community testing programme for COVID-19 in London: Lessons learnt.

A. Whittington, L. John, A. Goodman, 2020, Clinical medicine.

Infectious causes of fever of unknown origin.

D. Moore, A. McGregor, 2015, Clinical medicine.

Clinical and Diagnostic Features of 413 Patients Treated for Imported Strongyloidiasis at the Hospital for Tropical Diseases, London

M. Armstrong, C. Whitty, P. Chiodini, 2019, The American journal of tropical medicine and hygiene.

Cross-sectional observational study of epidemiology of COVID-19 and clinical outcomes of hospitalised patients in North West London during March and April 2020

R. Manuel, M. Kuper, S. Hiles, 2021, BMJ Open.

Studies on the host-parasite relationship in Schistosoma mansoni-infected mice: the immunological dependence of parasite egg excretion.

M. Doenhoff, A. McGregor, J. Bain, 1978, Immunology.

Hyperreactive Malarial Splenomegaly Syndrome--Can the Diagnostic Criteria Be Improved?

P. Chiodini, W. Newsholme, A. McGregor, 2015, The American journal of tropical medicine and hygiene.

Falciparum malaria as a cause of fever in adult travellers returning to the United Kingdom: observational study of risk by geographical area.

M. Armstrong, C. Whitty, A. Ustianowski, 2008, QJM : monthly journal of the Association of Physicians.

Management of quinolone-resistant typhoid osteomyelitis.

Michael Brown, S. Morris-Jones, D. Armstrong-James, 2011, British journal of hospital medicine.

Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial

Scott M Elliott, J. Haughney, V. Libri, 2021, The Lancet.

Schistosoma mansoni infections in T-cell deprived mice, and the ameliorating effect of administering homologous chronic infection serum. I. Pathogenesis.

M. Doenhoff, A. McGregor, J. Bain, 1979, The American journal of tropical medicine and hygiene.

Fulminant amoebic colitis following loperamide use.

K. Thway, S. Wright, A. McGregor, 2007, Journal of travel medicine.

Factors affecting the acquisition of resistance against Schistosoma mansoni in the mouse: III. The failure of primary infections with cercariae of one sex to induce resistance to reinfection.

M. Doenhoff, Q. Bickle, A. McGregor, 1979, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Factors affecting the acquisition of resistance against Schistosoma mansoni in the mouse. I. Demonstration of resistance to reinfection using a model system that involves perfusion of mice within three weeks of challenge

M. Doenhoff, Q. Bickle, A. McGregor, 1978, Journal of Helminthology.

A cavitating pulmonary lesion with eosinophilia

W. Newsholme, A. McGregor, N. Griffin, 2012, Thorax.

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial

D. Bonsall, V. Libri, J. Vekemans, 2021, The Lancet.

Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial

J. Haughney, V. Libri, M. Kamal, 2022, The Lancet Infectious Diseases.

Clinical features and management of individuals admitted to hospital with monkeypox and associated complications across the UK: a retrospective cohort study.

Mayur R Gamit, J. Canny, M. Beadsworth, 2022, The Lancet. Infectious diseases.

Efficacy of ChAdOx1 nCoV-19 (AZD1222) Vaccine Against SARS-CoV-2 VOC 202012/01 (B.1.1.7)

D. Bonsall, V. Libri, J. Vekemans, 2021 .

Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infection

J. Knight, V. Libri, A. Mentzer, 2022, Nature Medicine.

False-negative RT-PCR for COVID-19 and a diagnostic risk score: a retrospective cohort study among patients admitted to hospital

Harmeet Chana, A. Whittington, A. Gupta-Wright, 2021, BMJ Open.

Serum protein concentrations during Schistosoma mansoni infection in intact and T-cell deprived mice. II. Immunoglobulin G and antibodies specific for heterologous erythrocytes.

M. Doenhoff, A. McGregor, J. Bain, 1980, Immunology.

Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome.

T. Sorrell, M. Richards, T. Gottlieb, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Propionibacterium acnes as a cause of lung abscess in a cardiac transplant recipient

S. Morris-Jones, D. Veitch, A. McGregor, 2015, BMJ Case Reports.

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial

D. Bonsall, V. Libri, J. Vekemans, 2021, The Lancet.